In a land of giants, we help you stand tall.
Released: 25-May-2017 | Last Updated: 25-May-2017 03:43 PM
Roundup is the commercial name for the herbicide glyphosate, produced and distributed worldwide by Monsanto. In 2015, the International Agency for Research on Cancer identified this herbicide to be a probable human carcinogenic. Despite this finding, as well as additional studies, Monsanto denies this finding, as well as claims that it knew of this danger yet minimized this risk information.
Who is at Risk?
Prolonged exposure to Roundup increases the risk of developing non-Hodgkin lymphoma, which is a cancer of the lymphatic system. Those at high risk of developing cancer include:
Most household users of Roundup with limited exposure are at low risk of developing cancer.
Studies Linking Roundup and Non-Hodgkin Lymphoma
Since the 1970s, studies have found a direct correlation between Roundup and non-Hodgkin lymphoma (NHL) in rodents, as well as a genotoxic effects in humans. This means that mutates human DNA, often resulting in cancer. Despite these findings, there have been no governmental requirements for warnings on the Roundup labels or the discontinuation of the product.
The link between Roundup and non-Hodgkin’s lymphoma gained renewed attention in March of 2015, when the International Agency on Cancer Research, which is part of the World Health Organization (WHO), declared Roundup “probable human carcinogen.” This finding was based on three independent studies that all reached the same conclusions.
As a result, several individual and class-action lawsuits have been filed against Monsanto. If you have been diagnosed with non-Hodgkin’s lymphoma that you believe was caused by Roundup, contact us immediately for a free consultation.
What is Non-Hodgkin Lymphoma?
Non-Hodgkin lymphoma is the most common cancer diagnosis connected with Roundup. It is a disease of the lymph system, which is a part of your immune system, which helps fight infections and some diseases. It also helps move fluids through the body. NHL can start in any part of the lymph system, and is often identified by swollen lymph nodes. It can quickly spread throughout the lymph system and then to other parts of the body, including the brain, liver, and bone marrow. There are two categories of NHL:
A biopsy is most often used to test and diagnose NHL, though other diagnostic tools may also be used, including blood tests and imaging (MRI, X-ray, CT scan, etc.)
There are several subtypes of NHL, each with their own aggression and survival rates. The primary treatments for NHL are:
Signs and Symptoms of Non-Hodgkin Lymphoma
Because it is based in the lymph system, Non-Hodgkin lymphoma (NHL) can manifest in different ways and places in the body. Some common signs and symptoms include:
Please note that these are generalized symptoms that can indicate a variety of non-life-threatening conditions and it is important to contact a healthcare professional for evaluation.
How We Can Help
The attorneys of Barfoot & Schoettker are focused on helping those injured by defective products and are willing to speak with you today about the Roundup lawsuit. We deliver the expertise and services you need, with the personalized attention you deserve. If you have been diagnosed with non-Hodgkin’s lymphoma and you believe it is due to Roundup exposure, contact us today. We do not charge a fee for a consultation regarding your potential claim against Roundup.